Inhibition of NF-κB activation by a novel IKK inhibitor reduces the severity of experimental autoimmune myocarditis via suppression of T-cell activation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of NF-κB activation by a novel IKK inhibitor reduces the severity of experimental autoimmune myocarditis via suppression of T-cell activation
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 305, Issue 12, Pages H1761-H1771
Publisher
American Physiological Society
Online
2013-10-05
DOI
10.1152/ajpheart.00159.2013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of IκB phosphorylation prevents load-induced cardiac dysfunction in mice
- (2012) Tetsu Tanaka et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- A PP4 Holoenzyme Balances Physiological and Oncogenic Nuclear Factor-Kappa B Signaling in T Lymphocytes
- (2012) Markus Brechmann et al. IMMUNITY
- A Novel IKK Inhibitor Prevents Progression of Restenosis After Arterial Injury in Mice
- (2012) Rikuta Hamaya et al. International Heart Journal
- Impaired post-infarction cardiac remodeling in chronic kidney disease is due to excessive renin release
- (2012) Masahito Ogawa et al. LABORATORY INVESTIGATION
- Mesenchymal Stromal Cells but Not Cardiac Fibroblasts Exert Beneficial Systemic Immunomodulatory Effects in Experimental Myocarditis
- (2012) Konstantinos Savvatis et al. PLoS One
- Inflammatory signaling in macrophages: Transitions from acute to tolerant and alternative activation states
- (2011) Lionel B. Ivashkiv EUROPEAN JOURNAL OF IMMUNOLOGY
- Novel IκB kinase inhibitors for treatment of nuclear factor-κB-related diseases
- (2011) Jun-Ichi Suzuki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The Anti-Inflammatory Mechanism of Prostaglandin E2 Receptor 4 Activation in Rat Experimental Autoimmune Myocarditis
- (2011) Pham Bao Ngoc et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Angiotensin-Converting Enzyme Inhibition Prevents the Release of Monocytes From Their Splenic Reservoir in Mice With Myocardial Infarction
- (2010) Florian Leuschner et al. CIRCULATION RESEARCH
- IκB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma
- (2010) H. Ogawa et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Immunohistochemical characterization of infiltrating mononuclea cells in the rat heart with experimental autoimmune giant cell myocarditis
- (2010) M. KODAMA et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Aldosterone-induced kidney injury is mediated by NFκB activation
- (2010) Seiichi Fukuda et al. Clinical and Experimental Nephrology
- Regulation of interferon-γ, interleukin-4 and interleukin-2 by Schizonepeta tenuifolia through differential effects on nuclear factor-κB, NFATc2 and STAT4/6
- (2010) Hee Kang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Autoimmune myocarditis: Past, present and future
- (2009) Florian Leuschner et al. JOURNAL OF AUTOIMMUNITY
- Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway
- (2009) Takaaki Haga et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration
- (2008) Shin Wakatsuki et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The IKK-NF-κB pathway: a source for novel molecular drug targets in pain therapy?
- (2008) Ellen Niederberger et al. FASEB JOURNAL
- Amelioration of myocarditis by statin through inhibiting cross-talk between antigen presenting cells and lymphocytes in rats
- (2008) Jia-lu Wu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started